FDA approves swallowable Allurion Gastric Balloon for weight loss in adults with obesity who failed prior lifestyle programs.

Zepbound KwikPen, a 4-dose single-patient delivery device for tirzepatide administration has been made available by Lilly.

Metabolic syndrome exacerbates inpatients outcomes and increased health care use among patients hospitalized with IBD.

The FDA proposed new guidelines for approving experimental therapies for rare diseases without large group studies.

Nutrition and lifestyle interventions, including whole-food plant-based diets, show promise in managing mood disorders and ...

Colorectal cancer was more common among patients with inflammatory bowel disease who had high-grade dysplasia.

Novo Nordisk has pledged to cut US list prices of Ozempic and Wegovy to about $675 per month starting January 1, 2027.

Ralph Abraham, the deputy secretary general of the CDC, stepped down effective immediately on Monday, February 23.

Approximately 21% and 9% of US adolescents have MASLD and related fibrosis, respectively. Prevalence remained before and during the COVID-19 pandemic.

MASLD is present in over 70% of outpatients with type 2 diabetes. In addition, a 2-tier screening approach is useful for liver fibrosis stratification.

Statin use among individuals with cirrhosis is associated with a significantly reduced risk for hepatocellular carcinoma, hepatic decompensation, and all-cause mortality.

Higher TSH and lower T3 levels are linked to an increased risk for major liver outcomes and major cardiovascular events among those with MASLD.